RAP1GAP and metabolic dysfunction-associated steatotic liver disease: In addition, a research by Agarwal [58] et al. on non-alcoholic fatty liver disease suggested that RAP1GAP can reduce the expression of genes involved in fat synthesis in obese mice, indicating a correlation between RAP1GAP and lipid metabolism.